Literature DB >> 9684578

Cytologic examination of urine from patients with interstitial cystitis.

L G Dodd1, J Tello.   

Abstract

OBJECTIVE: To perform a cytologic examination of urine from patients with interstitial cystitis (IC). STUDY
DESIGN: Patients included in this study fit the definition of IC established by the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases. Cytologic material was identified by checking the pathology archives against medical record numbers of patients with biopsy-confirmed IC. Cytologic preparations included cytocentrifuge samples and filters. Representative material was submitted for toluidine blue staining.
RESULTS: Thirty-three urine specimens from 14 patients with IC were included in the study. All urines showed acute inflammation, predominantly polymorphonuclear cells. Fourteen (42%) specimens contained eosinophils, and 10 (30%) contained cells resembling mast cells. Other findings included numerous degenerated cells, reactive transitional cells and hematuria. Toluidine blue staining of urine cytocentrifuge samples failed to demonstrate metachromatic staining of the presumed mast cells. DISCUSSION: Cytologic examination of urine from patients with IC showed consistent but nonetheless nonspecific findings. The predominant characteristic was the presence of inflammatory cells, mostly neutrophils and occasionally eosinophils.

Entities:  

Mesh:

Year:  1998        PMID: 9684578     DOI: 10.1159/000331969

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  8 in total

1.  Assessing urgency in interstitial cystitis/painful bladder syndrome.

Authors:  Christina Diggs; Walter A Meyer; Patricia Langenberg; Patty Greenberg; Linda Horne; John W Warren
Journal:  Urology       Date:  2007-01-31       Impact factor: 2.649

2.  Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC).

Authors:  Tony Y H Chen; Jacques Corcos; Michel Camel; Yves Ponsot; Le Mai Tu
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-04-08

3.  Mapping the cytokine profile of painful bladder syndrome/interstitial cystitis in human bladder and urine specimens.

Authors:  Anthony T Corcoran; Naoki Yoshimura; Vikas Tyagi; Bruce Jacobs; Wendy Leng; Pradeep Tyagi
Journal:  World J Urol       Date:  2012-03-24       Impact factor: 4.226

4.  Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage "leaky bladder" model of cystitis.

Authors:  Christopher D Engles; Paul J Hauser; Shivon N Abdullah; Daniel J Culkin; Robert E Hurst
Journal:  Urology       Date:  2011-12-02       Impact factor: 2.649

5.  Protective Effect of Purinergic P2X7 Receptor Inhibition on Acrolein-Induced Urothelial Cell Damage.

Authors:  Zhinoos Taidi; Kylie J Mansfield; Hafiz Sana-Ur-Rehman; Kate H Moore; Lu Liu
Journal:  Front Physiol       Date:  2022-04-12       Impact factor: 4.755

6.  The NLRP3 Inflammasome Inhibitor Dapansutrile Attenuates Cyclophosphamide-Induced Interstitial Cystitis.

Authors:  Sonia Kiran; Ahmed Rakib; Udai P Singh
Journal:  Front Immunol       Date:  2022-06-03       Impact factor: 8.786

7.  Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome.

Authors:  Yuan-Hong Jiang; Chung-Hsin Peng; Hsin-Tzu Liu; Hann-Chorng Kuo
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

8.  The severity of experimental autoimmune cystitis can be ameliorated by anti-CXCL10 Ab treatment.

Authors:  Udai P Singh; Narendra P Singh; Honbing Guan; Venkatesh L Hegde; Robert L Price; Dennis D Taub; Manoj K Mishra; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.